help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, P. M.
Right arrow Articles by Mason, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, P. M.
Right arrow Articles by Mason, J. I.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 885-890, Copyright © 1995 by Endocrine Society

ARTICLES

Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis

PM Stewart, FM Rogerson and JI Mason
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, 75235-9051.

Two isoforms of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) have been described which catalyze the interconversion of cortisol (F) to cortisone (E). 11 beta HSD activity has previously been reported in placenta and fetal membranes, where its role may be to protect the developing fetus from glucocorticoid excess. Furthermore, in the rat, an association between placental 11 beta HSD activity and the subsequent development of hypertension in the offspring has been reported. We have characterized the isoforms of 11 beta HSD in human fetal membranes and dissected placental tissue at term and investigated the relationship between placental 11 beta HSD activity and fetal and placental weights. 11 beta HSD activity studies in the presence of 0.1 mumol/L F and NAD (indicative of type 2 isoform activity) revealed high levels of activity in trophoblast dissected free of vessels (561 +/- 87 pmol E/h.mg protein; n = 4) > undissected placenta > cotyledenous vessels dissected away from trophoblast > placental and reflected amnion. In contrast, in the presence of 2.5 mumol/L F and NADP (indicative of type 1 isoform activity), only decidua and chorion demonstrated significant levels of 11 beta HSD activity. Type 1 11 beta HSD activity in chorion was probably due to decidual contamination, in that it was absent in decidua-free fused chorion obtained from a twin pregnancy. In keeping with these data, type 1 11 beta HSD messenger ribonucleic acid (1.5 kilobases) was detected in decidua, but in no other tissue, and high levels of type 2 11 beta HSD messenger ribonucleic acid (1.9 kilobases) were found in undissected placenta and trophoblast. In 27 term placentas, 11 beta HSD activity varied from 194- 448 pmol E/h.mg protein. There was a weak, but significant, positive correlation between term placental 11 beta HSD activity and fetal weight (r = 0.408; P = 0.034), but no correlation with placental weight. Thus, in man, the reported association of a small fetus and a large placenta predisposing to adult hypertension cannot be explained on the basis of defective 11 beta HSD activity. However, the placenta offers an immense reservoir for F clearance (1.73-7.95 mumol/min.placenta) and may be a principal factor driving fetal ACTH secretion and, hence, fetal adrenal steroidogenesis.


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
A. E. Michael and A. T. Papageorghiou
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Hum. Reprod. Update, June 13, 2008; (2008) dmn021v1.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R Verkauskiene, J Beltrand, O Claris, D Chevenne, S Deghmoun, S Dorgeret, M Alison, P Gaucherand, O Sibony, and C Levy-Marchal
Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age
Eur. J. Endocrinol., November 1, 2007; 157(5): 605 - 612.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Jang, V. R. Obeyesekere, R. J. Dilley, Z. Krozowski, W. J. Inder, and F. P. Alford
Altered Activity of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Skeletal Muscle Confers Metabolic Protection in Subjects with Type 2 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3314 - 3320.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Mairesse, J. Lesage, C. Breton, B. Breant, T. Hahn, M. Darnaudery, S. L. Dickson, J. Seckl, B. Blondeau, D. Vieau, et al.
Maternal stress alters endocrine function of the feto-placental unit in rats
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1526 - E1533.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
C. J McNeil, M. O Nwagwu, A. M Finch, K. R Page, A. Thain, H. J McArdle, and C. J Ashworth
Glucocorticoid exposure and tissue gene expression of 11{beta} HSD-1, 11{beta} HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth
Reproduction, March 1, 2007; 133(3): 653 - 661.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. R. SECKL and M. J. MEANEY
Glucocorticoid "Programming" and PTSD Risk
Ann. N.Y. Acad. Sci., July 1, 2006; 1071(1): 351 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. Kossintseva, S. Wong, E. Johnstone, L. Guilbert, D. M. Olson, and B. F. Mitchell
Proinflammatory cytokines inhibit human placental 11{beta}-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E282 - E288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Yang, L. Julan, F. Rubio, A. Sharma, and H. Guan
Cadmium reduces 11{beta}-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E135 - E142.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
L. A M Welberg, K V Thrivikraman, and P. M Plotsky
Chronic maternal stress inhibits the capacity to up-regulate placental 11{beta}-hydroxysteroid dehydrogenase type 2 activity
J. Endocrinol., September 1, 2005; 186(3): R7 - R12.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Julan, H. Guan, J. P. van Beek, and K. Yang
Peroxisome Proliferator-Activated Receptor {delta} Suppresses 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Human Placental Trophoblast Cells
Endocrinology, March 1, 2005; 146(3): 1482 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. R. SECKL and M. J. MEANEY
Glucocorticoid Programming
Ann. N.Y. Acad. Sci., December 1, 2004; 1032(1): 63 - 84.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S McMullen, J C Osgerby, L M Thurston, T S Gadd, P J Wood, D C Wathes, and A E Michael
Alterations in placental 11{beta}-hydroxysteroid dehydrogenase (11{beta}HSD) activities and fetal cortisol:cortisone ratios induced by nutritional restriction prior to conception and at defined stages of gestation in ewes
Reproduction, June 1, 2004; 127(6): 717 - 725.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
P.M. Driver, S. Rauz, E.A. Walker, M. Hewison, M.D. Kilby, and P.M. Stewart
Characterization of human trophoblast as a mineralocorticoid target tissue
Mol. Hum. Reprod., December 1, 2003; 9(12): 793 - 798.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. S. Wilcoxon, J. Schwartz, F. Aird, and E. E. Redei
Sexually dimorphic effects of maternal alcohol intake and adrenalectomy on left ventricular hypertrophy in rat offspring
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E31 - E39.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Kajantie, L. Dunkel, U. Turpeinen, U.-H. Stenman, P. J. Wood, M. Nuutila, and S. Andersson
Placental 11{beta}-Hydroxysteroid Dehydrogenase-2 and Fetal Cortisol/Cortisone Shuttle in Small Preterm Infants
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 493 - 500.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. Sun, P. He, and K. Yang
Intracrine Induction of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression by Glucocorticoid Potentiates Prostaglandin Production in the Human Chorionic Trophoblast
Biol Reprod, November 1, 2002; 67(5): 1450 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. E. Murphy, T. Zakar, R. Smith, W. B. Giles, P. G. Gibson, and V. L. Clifton
Reduced 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated with Decreased Birth Weight Centile in Pregnancies Complicated by Asthma
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1660 - 1668.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. J. Bolt, M. M. van Weissenbruch, C. Popp-Snijders, C. G. J. Sweep, H. N. Lafeber, and H. A. Delemarre-van de Waal
Fetal Growth and the Function of the Adrenal Cortex in Preterm Infants
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1194 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. L. McTernan, N. Draper, H. Nicholson, S. M. Chalder, P. Driver, M. Hewison, M. D. Kilby, and P. M. Stewart
Reduced Placental 11{beta}-Hydroxysteroid Dehydrogenase Type 2 mRNA Levels in Human Pregnancies Complicated by Intrauterine Growth Restriction: An Analysis of Possible Mechanisms
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4979 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Lesage, B. Blondeau, M. Grino, B. Bréant, and J. P. Dupouy
Maternal Undernutrition during Late Gestation Induces Fetal Overexposure to Glucocorticoids and Intrauterine Growth Retardation, and Disturbs the Hypothalamo-Pituitary Adrenal Axis in the Newborn Rat
Endocrinology, May 1, 2001; 142(5): 1692 - 1702.
[Abstract] [Full Text]

Home page
 Mol Hum ReprodHome page
P.M. Driver, M.D. Kilby, I. Bujalska, E.A. Walker, M. Hewison, and P.M. Stewart
Expression of 11{beta}-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies
Mol. Hum. Reprod., April 1, 2001; 7(4): 357 - 363.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Schoof, M. Girstl, W. Frobenius, M. Kirschbaum, H. G. Dörr, W. Rascher, and J. Dötsch
Decreased Gene Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 and 15-Hydroxyprostaglandin Dehydrogenase in Human Placenta of Patients with Preeclampsia
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1313 - 1317.
[Abstract] [Full Text]

Home page
 HypertensionHome page
C.-B. Lanz, M. Causevic, C. Heiniger, F. J. Frey, B. M. Frey, and M. G. Mohaupt
Fluid Shear Stress Reduces 11{beta}-Hydroxysteroid Dehydrogenase Type 2
Hypertension, January 1, 2001; 37(1): 160 - 169.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye
Endocrine and Paracrine Regulation of Birth at Term and Preterm
Endocr. Rev., October 1, 2000; 21(5): 514 - 550.
[Abstract] [Full Text]

Home page
 HypertensionHome page
R. Alzamora, L. Michea, and E. T. Marusic
Role of 11{beta}-Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries
Hypertension, May 1, 2000; 35(5): 1099 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. C. McMillen, K. E. Warnes, M. B. Adams, J. S. Robinson, J. A. Owens, and C. L. Coulter
Impact of Restriction of Placental and Fetal Growth on Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 and Type 2 Messenger Ribonucleic Acid in the Liver, Kidney, and Adrenal of the Sheep Fetus
Endocrinology, February 1, 2000; 141(2): 539 - 543.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
D. V Milford
Investigation of hypertension and the recognition of monogenic hypertension
Arch. Dis. Child., November 1, 1999; 81(5): 452 - 455.
[Full Text] [PDF]

Home page
 Biol. Reprod.Home page
D.B. Hardy, L.E. Pereria, and K. Yang
Prostaglandins and Leukotriene B4 Are Potent Inhibitors of 11ß-Hydroxysteroid Dehydrogenase Type 2 Activity in Human Choriocarcinoma JEG-3 Cells
Biol Reprod, July 1, 1999; 61(1): 40 - 45.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
J. Tremblay, D.B. Hardy, L.E. Pereira, and K. Yang
Retinoic Acid Stimulates the Expression of 11ß-Hydroxysteroid Dehydrogenase Type 2 in Human Choriocarcinoma JEG-3 Cells
Biol Reprod, March 1, 1999; 60(3): 541 - 545.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. A. Patel, K. Sun, and J. R. G. Challis
Local Modulation by 11{beta}-Hydroxysteroid Dehydrogenase of Glucocorticoid Effects on the Activity of 15-Hydroxyprostaglandin Dehydrogenase in Human Chorion and Placental Trophoblast Cells
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 395 - 400.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
P. J. Burton and B. J. Waddell
Dual Function of 11ß-Hydroxysteroid Dehydrogenase in Placenta: Modulating Placental Glucocorticoid Passage and Local Steroid Action
Biol Reprod, February 1, 1999; 60(2): 234 - 240.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Condon, C. Gosden, D. Gardener, P. Nickson, M. Hewison, A. J. Howie, and P. M. Stewart
Expression of Type 2 11{beta}-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4490 - 4497.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
R. Sampath-Kumar, S.G. Matthews, and K. Yang
11ß-Hydroxysteroid Dehydrogenase Type 2 Is the Predominant Isozyme in the Guinea Pig Placenta: Decreases in Messenger Ribonucleic Acid and Activity at Term
Biol Reprod, December 1, 1998; 59(6): 1378 - 1384.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Dave-Sharma, R. C. Wilson, M. D. Harbison, R. Newfield, M. R. Azar, Z. S. Krozowski, J. W. Funder, C. H. L. Shackleton, H. L. Bradlow, J.-Q. Wei, et al.
Examination of Genotype and Phenotype Relationships in 14 Patients with Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2244 - 2254.
[Abstract] [Full Text]

Home page
 Cardiovasc ResHome page
S. H.M. van Uum, A. R.M.M. Hermus, P. Smits, T. Thien, and J. W.M. Lenders
The role of 11{beta}-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Cardiovasc Res, April 1, 1998; 38(1): 16 - 24.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. E. Smith, L. A. Salamonsen, P. A. Komesaroff, K. X. Z. Li, K. M. Myles, M. Lawrence, and Z. Krozowski
11{beta}-Hydroxysteroid Dehydrogenase Type II in the Human Endometrium: Localization and Activity during the Menstrual Cycle
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4252 - 4257.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Sun, K. Yang, and J. R. G. Challis
Differential Regulation of 11 {beta}-Hydroxysteroid Dehydrogenase Type 1 and 2 by Nitric Oxide in Cultured Human Placental Trophoblast and Chorionic Cell Preparation
Endocrinology, November 1, 1997; 138(11): 4912 - 4920.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. X. Z. Li, V. R. Obeyesekere, Z. S. Krozowski, and P. Ferrari
Oxoreductase and Dehydrogenase Activities of the Human and Rat 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Enzyme
Endocrinology, July 1, 1997; 138(7): 2948 - 2952.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
J. Bissonnette, S. Chambers, P. Collins, C. Lockwood, C. Mendelson, L. Myatt, M. L. Polan, W. H. Shen, and S. Szal
Strengthening Research in Departments of Obstetrics and Gynecology
Reproductive Sciences, May 1, 1997; 4(3): 124 - 129.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
P. C. White, T. Mune, and A. K. Agarwal
11{beta}-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess
Endocr. Rev., February 1, 1997; 18(1): 135 - 156.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Sun, K. Yang, and J. R. G. Challis
Differential Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Human Placenta and Fetal Membranes
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 300 - 305.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. C. White
Inherited Forms of Mineralocorticoid Hypertension
Hypertension, December 1, 1996; 28(6): 927 - 936.
[Abstract] [Full Text]

Home page
 HypertensionHome page
R. S. Lindsay, R. M. Lindsay, C. R.W. Edwards, and J. R. Seckl
Inhibition of 11ß-Hydroxysteroid Dehydrogenase in Pregnant Rats and the Programming of Blood Pressure in the Offspring
Hypertension, June 1, 1996; 27(6): 1200 - 1204.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society